Novacyt (FR:ALNOV) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Novacyt S.A., a French-based international specialist in clinical diagnostics, has reported transactions of ordinary shares through its liquidity agreement with Invest Securities SA, with a total of 82,719 shares purchased and 27,145 sold in September 2024. The company currently holds 76,010 treasury shares and has a total of 70,626,248 ordinary shares, affecting the voting rights of its shareholders. Novacyt operates in multiple sectors, including human and animal health, and is present in over 65 countries.
For further insights into FR:ALNOV stock, check out TipRanks’ Stock Analysis page.
